Cefrre (Ceftriaxone Sodium USP), Broad Spectrum Antibiotic Injection IM/IV, 250, 500, 1000 & 2000 mg

Cefrre (Ceftriaxone Sodium USP), Broad Spectrum Antibiotic Injection IM/IV, 250, 500, 1000 & 2000 mg
Amson Vaccines and Pharmaceutical Private Limited introduces Cefrre, a powerful formulation containing Ceftriaxone Sodium USP. This advanced antibiotic provides extensive coverage for surgical prophylaxis, including orthopaedic surgery, neurosurgery, general surgery, cardiothoracic surgery, and gynae-obstetric surgery. Backed by the Anti-Microbial Guidelines 2016, Cefrre is proven to be superior in preventing post-operative infections, offering a rapid clinical response and a high success rate across various surgeries. With single-dose pre-operative recommendations and a remarkable efficacy rate, Cefrre is the preferred choice for ensuring surgical success and managing infections like typhoid fever, pneumonia, and bacterial meningitis. It reduces hospital stays, lowers treatment costs, and provides exceptional compliance with convenient dosing. Whether for adults or children, Cefrre delivers broad-spectrum antibacterial action, making it an indispensable antibiotic for healthcare professionals.
#Cefrre #CeftriaxoneSodium #AmsonVaccines #CefrreInjection #CeftriaxoneUSP #AmsonPharma #CefrreIV #CefrreIM #CeftriaxoneForSurgery #SurgicalProphylaxis #OrthopedicSurgery #Neurosurgery #CardiothoracicSurgery #GyneObsSurgery #PostOperativeInfections #TyphoidTreatment #PneumoniaTreatment #BacterialMeningitis #SevereCAP #AntibacterialAction #BroadSpectrumAntibiotic #BactericidalEffect #EffectiveInTyphoid #BacterialMeningitisCure #RapidResponse #ReducesHospitalStay #HighSuccessRate #CostEffectiveTreatment #SafeAndEffective #ConvenientDosing